# US Inhaled Insulin Dose Titration Study

> **NCT00246623** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 120 (—)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Exubera (inhaled insulin)
- **PROCEDURE:** 8-point glucose diary (to assess pre- and post prandial glucoses)
- **PROCEDURE:** Meal Tolerance Test
- **PROCEDURE:** 24-hour continuous glucose monitoring (at select sites)
- **PROCEDURE:** Pulmonary Function Testing
- **PROCEDURE:** Hypoglycemic Event Monitoring
- **PROCEDURE:** Laboratory Assessments
- **BEHAVIORAL:** Nutritional Counseling and Diabetes Education

## Key facts

- **NCT ID:** NCT00246623
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 120 (—)
- **Last updated:** 2008-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00246623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00246623, "US Inhaled Insulin Dose Titration Study". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00246623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*